| Application no. and date | 02785718.4 (espacenet) (Federated) (European Patent Register), 20021104 | | Patent/reg. no. and date | DK/EP 1448235, 20070314 | | Publication date | 20040825 | | Priority no. and date | US 334652 P, 20011130 | | EP pub. no. and date |
EP 1448235 20040825 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P80701261DK00E | | Inventor | AM ENDE, Mary Tanya, Pfizer Global Res. & Dev.
Eastern Point Road
Groton, CT 06340, US,
ROY, Michael Christopher, Pfizer Global Res. & Dev.
Eastern Point Road
Groton, CT 06340, US,
SMITH, Scott Wendell
Pfizer Global Res. & Dev., 10777 Science Center Drive
San Diego, CA 92121, US,
WATERMAN, Kenneth Craig
Pfizer Global Res. & Dev., Eastern Point Road
Groton, CT 06340, US,
MOSES, Sara Kristen
Pfizer Global Res. & Dev., Eastern Point Road
Groton, CT 06340, US,
QUAN, Ernest Shing
Pfizer Global Res. & Dev., Eastern Point Road
Groton, CT 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4995 (2006.01) , A61P 25/34 (2006.01) | | Title | Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse | | Int. application no. | IB2002004612 | | Int. publication no. | WO2003045437 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
